Hodgkin's Lymphoma Treatment Market Growth Accelerated By Increasing Incidence Of Hodgkin Lymphoma

 
Hodgkin's Lymphoma Treatment 

Hodgkin lymphoma is a type of cancer that starts in lymphatic system and white blood cells. Hodgkin lymphoma treatment involves chemotherapy, radiation therapy or stem cell transplantation. Chemotherapy drugs are used to fight cancer cells and reduce their growth and spread in the body. Radiation therapy uses high-energy beams to kill cancer cells without affecting surrounding healthy tissues. Stem cell transplantation is a medical procedure wherein healthy stem cells are transfused into a patient to replace damaged or unhealthy cells of lymphatic and immune systems.

The global Hodgkins Lymphoma Treatment Market is estimated to be valued at US$ 0.59 Bn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The increasing incidence of Hodgkin lymphoma has been a key growth driver for the Hodgkins lymphoma treatment market. According to Cancer Research UK, the lifetime risk of developing Hodgkin lymphoma in UK is 1 in 150 for both men and women. WHO estimates around 72,000 new cases and 20,000 deaths due to Hodgkin lymphoma every year globally. The growing geriatric population, which is more susceptible to cancer, and advancements in treatment options for Hodgkin lymphoma like personalized medicine approaches are also contributing to the increasing demand for Hodgkin lymphoma treatment market.

Segment Analysis
The global Hodgkins Lymphoma Treatment market is dominated by chemotherapy sub segment. Chemotherapy involves using powerful drugs to destroy fast-growing cancer cells and is widely used for treating Hodgkin's lymphoma. Several types of chemotherapy drugs can be combined to treat Hodgkin's lymphoma depending on the stage and other factors. Since, chemotherapy is the standard first-line treatment for Hodgkins lymphoma and is very effective against the malignant lymphoma cells, the chemotherapy sub segment is dominating the market currently.

Key Takeaways
The global Hodgkins Lymphoma Treatment market analysis is expected to witness high growth during the forecast period of 2023 to 2030.

Europe currently dominates the regional market for Hodgkins Lymphoma Treatment due to high prevalence rates and better access to advanced treatment options in countries like Germany, France and the UK. The Asia Pacific region is expected to be the fastest growing market due to improving healthcare infrastructure and increasing awareness about cancer diagnosis and treatment in major Asian countries.

Key players operating in the Hodgkins Lymphoma Treatment market are Medtronic PLC, ICU Medical, Inc., Viggo Medical Devices, Teleflex Incorporated, Olympus America, Polymedicure, Ambu A/S., Verathon Inc., SourceMark, SunMed, KARL STORZ, Flexicare (Group) Limited, and Vyaire Medical. Medtronic PLC offers Oncology solutions for diagnosis, guidance and drug delivery. ICU Medical, Inc. provides secure medical device connector systems for clinical application.

Get more insights on this topic: https://www.newswirestats.com/hodgkins-lymphoma-treatment-market-industry-insights-trends-hodgkins-lymphoma-treatment-market/

Explore more information on this topic, Please visit: https://www.newsintv.com/health/genetic-symphony-precision-medicines-melody-for-tailored-health-and-wellness/

Comments

Popular posts from this blog

The Global Coffee Market Growth Accelerated By Demand From Millennials And Gen Z Population

The Global Ammonium Nitrate Market Growth Accelerated By Rising Demand From Agriculture Industry

Combined Heat And Power (CHP) Market Growth Accelerated By Increased Adoption Of Decentralized Power Systems